BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Staging
7 results:

  • 1. MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
    Wang C; Uemura M; Tomiyama E; Matsushita M; Koh Y; Nakano K; Hayashi Y; Ishizuya Y; Jingushi K; Kato T; Hatano K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Tsujikawa K; Nonomura N
    Cancer Sci; 2020 Apr; 111(4):1146-1155. PubMed ID: 31975504
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, mtor, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence.
    Lee L; Ito T; Jensen RT
    Expert Opin Pharmacother; 2018 Jun; 19(8):909-928. PubMed ID: 29757017
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?
    Anselmo Da Costa I; Rausch S; Kruck S; Todenhöfer T; Stenzl A; Bedke J
    Expert Rev Anticancer Ther; 2017 Apr; 17(4):357-368. PubMed ID: 28162024
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of HHV-8 and mtor pathway in post-transplant Kaposi sarcoma staging.
    Hernández-Sierra A; Rovira J; Petit A; Moya-Rull D; Mazuecos MA; Sánchez-Fructuoso AI; Errasti P; Idoate MÁ; Cruzado JM; Vidal A; Diekmann F; Oppenheimer F; Campistol JM; Revuelta I
    Transpl Int; 2016 Sep; 29(9):1008-16. PubMed ID: 27208691
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
    Amato RJ; Flaherty AL; Stepankiw M
    Clin Genitourin Cancer; 2012 Mar; 10(1):26-31. PubMed ID: 22169794
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.
    Jiang X; Kenerson H; Aicher L; Miyaoka R; Eary J; Bissler J; Yeung RS
    Am J Pathol; 2008 Jun; 172(6):1748-56. PubMed ID: 18511518
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.